A detailed history of Ensign Peak Advisors, Inc transactions in Organon & Co. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 69,009 shares of OGN stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,009
Previous 69,009 -0.0%
Holding current value
$1.03 Million
Previous $1.43 Million 7.56%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$13.78 - $18.8 $47,968 - $65,442
-3,481 Reduced 4.8%
69,009 $1.3 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $173,815 - $222,162
-9,020 Reduced 11.07%
72,490 $1.51 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $76,940 - $115,231
3,592 Added 4.61%
81,510 $1.92 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $64,731 - $79,449
-2,777 Reduced 3.44%
77,918 $2.18 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $66,456 - $97,270
2,840 Added 3.65%
80,695 $1.89 Million
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $265,469 - $326,176
-8,385 Reduced 9.72%
77,855 $2.63 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $624,681 - $807,470
20,515 Added 31.21%
86,240 $3.01 Million
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $1.39 Million - $1.79 Million
-48,337 Reduced 42.38%
65,725 $2 Million
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $4.48 Million - $5.58 Million
-156,611 Reduced 57.86%
114,062 $3.74 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $7.7 Million - $10.3 Million
270,673 New
270,673 $8.19 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.